|
Parameter values describing the parsimonious model |
||||||
| Model Parameters |
HBV |
95% C. I. |
HCV |
95% C. I. |
Global |
95% C. I. |
|
|
||||||
| g(t) trend in the FOI by year 1999–2003 |
||||||
| 1999–2003 |
0.1079 |
(0.0840–0.1327) |
0.1608 |
(0.1314–0.1942) |
||
| h(τ) trend in the FOI by injecting career length |
||||||
| <1 |
1 |
fixed |
Same as HBV |
|||
| 1+ |
0.3272 |
(0.2359–0.4443) |
Same as HBV |
|||
| HBV background prevalence b |
0 |
(0.0–0.0161) |
||||
| Frailty θ |
0.6566 |
(0.5305–0.8224) |
||||
| U -0.132 |
-2.524 |
|||||
| V 0.117 |
0.026 |
|||||
| W 63.99 |
77.52 |
|||||
| Z 295.5 |
19.49 |
|||||
Sutton et al. BMC Infectious Diseases 2006 6:93 doi:10.1186/1471-2334-6-93 |
||||||